Sergiy Libert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sergiy Libert has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
Scott D. Pletcher
Department of Molecular and Integrative Physiology and Geriatrics Center, University of Michigan, Ann Arbor, MI 48109, USA
5 shared publicationsVladimir Privman
Department of Physics Clarkson University 13699 Potsdam NY USA
5 shared publications- Adam B. Francisco
Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York
4 shared publications - Leonard Guarente
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA
4 shared publications - Vyacheslav N. Gorshkov
Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
4 shared publications Alex Chekholko
Calico Life Sciences
3 shared publications
Latest Publications
- Open Access
- 11 June 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
A mathematical model that predicts human biological age from physiological traits identifies environmental and genetic factors that influence aging
Why people age at different rates is a fundamental, unsolved problem in biology. We created a model that predicts an individual’s age from physiological traits that change with age in the large UK Biobank dataset, such as blood pressure, lung function, strength, and stimulus-reaction time. The model predicted a person’s age with best accuracy when it heavily weighted traits that together query multiple organ systems, arguing that most or all physiological systems (lung, heart, brain, etc.) contribute to the global phenotype of chronological age. Differences between calculated ‘biological’ age and chronological age (∆Age) appear to reflect an individual’s relative youthfulness, as people predicted to be young for their age had a lower subsequent mortality rate and a higher parental age at death, even though no mortality data were used to calculate ∆Age. Remarkably, the effect of each year of physiological ∆Age on Gompertz mortality risk was equivalent to that of one chronological year. A genome-wide association study (GWAS) of ∆Age and analysis of environmental factors associated with ∆Age identified known as well as new factors that may influence human aging, including genes involved in synapse biology and a tendency to play computer games. We identify a small number of readily measured physiological traits that together assess a person’s biological age and may be used clinically to evaluate therapeutics designed to slow aging and extend healthy life.
- 11 June 2025
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessA mathematical model that predicts human biological age from physiological traits identifies environmental and genetic factors that influence aging
Why people age at different rates is a fundamental, unsolved problem in biology. We created a model that predicts an individual’s age from physiological traits that change with age in the large UK Biobank dataset, such as blood pressure, lung function, strength, and stimulus-reaction time. The model predicted a person’s age with best accuracy when it heavily weighted traits that together query multiple organ systems, arguing that most or all physiological systems (lung, heart, brain, etc.) contribute to the global phenotype of chronological age. Differences between calculated ‘biological’ age and chronological age (∆Age) appear to reflect an individual’s relative youthfulness, as people predicted to be young for their age had a lower subsequent mortality rate and a higher parental age at death, even though no mortality data were used to calculate ∆Age. Remarkably, the effect of each year of physiological ∆Age on Gompertz mortality risk was equivalent to that of one chronological year. A genome-wide association study (GWAS) of ∆Age and analysis of environmental factors associated with ∆Age identified known as well as new factors that may influence human aging, including genes involved in synapse biology and a tendency to play computer games. We identify a small number of readily measured physiological traits that together assess a person’s biological age and may be used clinically to evaluate therapeutics designed to slow aging and extend healthy life.
- Open Access
- 19 March 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
A mathematical model that predicts human biological age from physiological traits identifies environmental and genetic factors that influence aging
Why people age at different rates is a fundamental, unsolved problem in biology. We created a model that predicts an individual’s age from physiological traits that change with age in the large UK Biobank dataset, such as blood pressure, lung function, strength and stimulus- reaction time. The model best predicted a person’s age when it heavily-weighted traits that together query multiple organ systems, arguing that most or all physiological systems (lung, heart, brain, etc.) contribute to the global phenotype of chronological age. Differences between calculated “biological” age and chronological age (ΔAge) appear to reflect an individual’s relative youthfulness, as people predicted to be young for their age had a lower subsequent mortality rate and a higher parental age at death, even though no mortality data were used to calculate ΔAge. Remarkably, the effect of each year of physiological ΔAge on Gompertz mortality risk was equivalent to that of one chronological year. A Genome-Wide Association Study (GWAS) of ΔAge, and analysis of environmental factors associated with ΔAge identified known as well as new factors that may influence human aging, including genes involved in synapse biology and a tendency to play computer games. We identify a small number of readily measured physiological traits that together assess a person’s biological age and may be used clinically to evaluate therapeutics designed to slow aging and extend healthy life.
- 19 March 2025
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Open AccessA mathematical model that predicts human biological age from physiological traits identifies environmental and genetic factors that influence aging
Why people age at different rates is a fundamental, unsolved problem in biology. We created a model that predicts an individual’s age from physiological traits that change with age in the large UK Biobank dataset, such as blood pressure, lung function, strength and stimulus- reaction time. The model best predicted a person’s age when it heavily-weighted traits that together query multiple organ systems, arguing that most or all physiological systems (lung, heart, brain, etc.) contribute to the global phenotype of chronological age. Differences between calculated “biological” age and chronological age (ΔAge) appear to reflect an individual’s relative youthfulness, as people predicted to be young for their age had a lower subsequent mortality rate and a higher parental age at death, even though no mortality data were used to calculate ΔAge. Remarkably, the effect of each year of physiological ΔAge on Gompertz mortality risk was equivalent to that of one chronological year. A Genome-Wide Association Study (GWAS) of ΔAge, and analysis of environmental factors associated with ΔAge identified known as well as new factors that may influence human aging, including genes involved in synapse biology and a tendency to play computer games. We identify a small number of readily measured physiological traits that together assess a person’s biological age and may be used clinically to evaluate therapeutics designed to slow aging and extend healthy life.
- Open Access
- 28 November 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (12) , pgae499
Disagreement on foundational principles of biological aging
To gain insight into how researchers of aging perceive the process they study, we conducted a survey among experts in the field. While highlighting some common features of aging, the survey exposed broad disagreement on the foundational issues. What is aging? What causes it? When does it begin? What constitutes rejuvenation? Not only was there no consensus on these and other core questions, but none of the questions received a majority opinion—even regarding the need for consensus itself. Despite many researchers believing they understand aging, their understanding diverges considerably. Importantly, as different processes are labeled as “aging” by researchers, different experimental approaches are prioritized. The survey shed light on the need to better define which aging processes this field should target and what its goals are. It also allowed us to categorize contemporary views on aging and rejuvenation, revealing critical, yet largely unanswered, questions that appear disconnected from the current research focus. Finally, we discuss ways to address the disagreement, which we hope will ultimately aid progress in the field.
- 28 November 2024
- Published by Oxford University Press (OUP) in PNAS Nexus
- Vol. 3 (12) , pgae499
Open AccessDisagreement on foundational principles of biological aging
To gain insight into how researchers of aging perceive the process they study, we conducted a survey among experts in the field. While highlighting some common features of aging, the survey exposed broad disagreement on the foundational issues. What is aging? What causes it? When does it begin? What constitutes rejuvenation? Not only was there no consensus on these and other core questions, but none of the questions received a majority opinion—even regarding the need for consensus itself. Despite many researchers believing they understand aging, their understanding diverges considerably. Importantly, as different processes are labeled as “aging” by researchers, different experimental approaches are prioritized. The survey shed light on the need to better define which aging processes this field should target and what its goals are. It also allowed us to categorize contemporary views on aging and rejuvenation, revealing critical, yet largely unanswered, questions that appear disconnected from the current research focus. Finally, we discuss ways to address the disagreement, which we hope will ultimately aid progress in the field.
- Open Access
A mathematical model that predicts human biological age from physiological traits identifies environmental and genetic factors that influence aging
Why people age at different rates is a fundamental, unsolved problem in biology. We created a model that predicts an individual’s age from physiological traits that change with age in the large UK Biobank dataset, such as blood pressure, lung function, strength and stimulus- reaction time. The model best predicted a person’s age when it heavily-weighted traits that together query multiple organ systems, arguing that most or all physiological systems (lung, heart, brain, etc.) contribute to the global phenotype of chronological age. Differences between calculated “biological” age and chronological age (ΔAge) appear to reflect an individual’s relative youthfulness, as people predicted to be young for their age had a lower subsequent mortality rate and a higher parental age at death, even though no mortality data were used to calculate ΔAge. Remarkably, the effect of each year of physiological ΔAge on Gompertz mortality risk was equivalent to that of one chronological year. A Genome-Wide Association Study (GWAS) of ΔAge, and analysis of environmental factors associated with ΔAge identified known as well as new factors that may influence human aging, including genes involved in synapse biology and a tendency to play computer games. We identify a small number of readily measured physiological traits that together assess a person’s biological age and may be used clinically to evaluate therapeutics designed to slow aging and extend healthy life.
Open AccessA mathematical model that predicts human biological age from physiological traits identifies environmental and genetic factors that influence aging
Why people age at different rates is a fundamental, unsolved problem in biology. We created a model that predicts an individual’s age from physiological traits that change with age in the large UK Biobank dataset, such as blood pressure, lung function, strength and stimulus- reaction time. The model best predicted a person’s age when it heavily-weighted traits that together query multiple organ systems, arguing that most or all physiological systems (lung, heart, brain, etc.) contribute to the global phenotype of chronological age. Differences between calculated “biological” age and chronological age (ΔAge) appear to reflect an individual’s relative youthfulness, as people predicted to be young for their age had a lower subsequent mortality rate and a higher parental age at death, even though no mortality data were used to calculate ΔAge. Remarkably, the effect of each year of physiological ΔAge on Gompertz mortality risk was equivalent to that of one chronological year. A Genome-Wide Association Study (GWAS) of ΔAge, and analysis of environmental factors associated with ΔAge identified known as well as new factors that may influence human aging, including genes involved in synapse biology and a tendency to play computer games. We identify a small number of readily measured physiological traits that together assess a person’s biological age and may be used clinically to evaluate therapeutics designed to slow aging and extend healthy life.
- Open Access
- 27 October 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (21) , 23872-23873
GWAS of canines identifies potential aging determinants
- 27 October 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (21) , 23872-23873
Open AccessGWAS of canines identifies potential aging determinants
- Open Access
- 4 June 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
SIRT1 accelerates the progression of activity-based anorexia
Food consumption is fundamental for life, and eating disorders often result in devastating or life-threatening conditions. Anorexia nervosa (AN) is characterized by a persistent restriction of energy intake, leading to lowered body weight, constant fear of gaining weight, and psychological disturbances of body perception. Herein, we demonstrate that SIRT1 inhibition, both genetically and pharmacologically, delays the onset and progression of AN behaviors in activity-based anorexia (ABA) models, while SIRT1 activation accelerates ABA phenotypes. Mechanistically, we suggest that SIRT1 promotes progression of ABA, in part through its interaction with NRF1, leading to suppression of a NMDA receptor subunit Grin2A. Our results suggest that AN may arise from pathological positive feedback loops: voluntary food restriction activates SIRT1, promoting anxiety, hyperactivity, and addiction to starvation, exacerbating the dieting and exercising, thus further activating SIRT1. We propose SIRT1 inhibition can break this cycle and provide a potential therapy for individuals suffering from AN.
- 4 June 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Open AccessSIRT1 accelerates the progression of activity-based anorexia
Food consumption is fundamental for life, and eating disorders often result in devastating or life-threatening conditions. Anorexia nervosa (AN) is characterized by a persistent restriction of energy intake, leading to lowered body weight, constant fear of gaining weight, and psychological disturbances of body perception. Herein, we demonstrate that SIRT1 inhibition, both genetically and pharmacologically, delays the onset and progression of AN behaviors in activity-based anorexia (ABA) models, while SIRT1 activation accelerates ABA phenotypes. Mechanistically, we suggest that SIRT1 promotes progression of ABA, in part through its interaction with NRF1, leading to suppression of a NMDA receptor subunit Grin2A. Our results suggest that AN may arise from pathological positive feedback loops: voluntary food restriction activates SIRT1, promoting anxiety, hyperactivity, and addiction to starvation, exacerbating the dieting and exercising, thus further activating SIRT1. We propose SIRT1 inhibition can break this cycle and provide a potential therapy for individuals suffering from AN.
- 1 April 2019
- Published by Springer Nature in GeroScience
- Vol. 41 (2) , 229-242
Cellular energetics and mitochondrial uncoupling in canine aging
The first domesticated companion animal, the dog, is currently represented by over 190 unique breeds. Across these numerous breeds, dogs have exceptional variation in lifespan (inversely correlated with body size), presenting an opportunity to discover longevity-determining traits. We performed a genome-wide association study on 4169 canines representing 110 breeds and identified novel candidate regulators of longevity. Interestingly, known functions within the identified genes included control of coat phenotypes such as hair length, as well as mitochondrial properties, suggesting that thermoregulation and mitochondrial bioenergetics play a role in lifespan variation. Using primary dermal fibroblasts, we investigated mitochondrial properties of short-lived (large) and long-lived (small) dog breeds. We found that cells from long-lived breeds have more uncoupled mitochondria, less electron escape, greater respiration, and capacity for respiration. Moreover, our data suggest that long-lived breeds have higher rates of catabolism and β-oxidation, likely to meet elevated respiration and electron demand of their uncoupled mitochondria. Conversely, cells of short-lived (large) breeds may accumulate amino acids and fatty acid derivatives, which are likely used for biosynthesis and growth. We hypothesize that the uncoupled metabolic profile of long-lived breeds likely stems from their smaller size, reduced volume-to-surface area ratio, and therefore a greater need for thermogenesis. The uncoupled energetics of long-lived breeds lowers reactive oxygen species levels, promotes cellular stress tolerance, and may even prevent stiffening of the actin cytoskeleton. We propose that these cellular characteristics delay tissue dysfunction, disease, and death in long-lived dog breeds, contributing to canine aging diversity.
- 1 April 2019
- Published by Springer Nature in GeroScience
- Vol. 41 (2) , 229-242
Cellular energetics and mitochondrial uncoupling in canine aging
The first domesticated companion animal, the dog, is currently represented by over 190 unique breeds. Across these numerous breeds, dogs have exceptional variation in lifespan (inversely correlated with body size), presenting an opportunity to discover longevity-determining traits. We performed a genome-wide association study on 4169 canines representing 110 breeds and identified novel candidate regulators of longevity. Interestingly, known functions within the identified genes included control of coat phenotypes such as hair length, as well as mitochondrial properties, suggesting that thermoregulation and mitochondrial bioenergetics play a role in lifespan variation. Using primary dermal fibroblasts, we investigated mitochondrial properties of short-lived (large) and long-lived (small) dog breeds. We found that cells from long-lived breeds have more uncoupled mitochondria, less electron escape, greater respiration, and capacity for respiration. Moreover, our data suggest that long-lived breeds have higher rates of catabolism and β-oxidation, likely to meet elevated respiration and electron demand of their uncoupled mitochondria. Conversely, cells of short-lived (large) breeds may accumulate amino acids and fatty acid derivatives, which are likely used for biosynthesis and growth. We hypothesize that the uncoupled metabolic profile of long-lived breeds likely stems from their smaller size, reduced volume-to-surface area ratio, and therefore a greater need for thermogenesis. The uncoupled energetics of long-lived breeds lowers reactive oxygen species levels, promotes cellular stress tolerance, and may even prevent stiffening of the actin cytoskeleton. We propose that these cellular characteristics delay tissue dysfunction, disease, and death in long-lived dog breeds, contributing to canine aging diversity.
- Open Access
- 8 November 2018
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 6 (1) , 120
Nicotine promotes neuron survival and partially protects from Parkinson’s disease by suppressing SIRT6
Parkinson’s disease is characterized by progressive death of dopaminergic neurons, leading to motor and cognitive dysfunction. Epidemiological studies consistently show that the use of tobacco reduces the risk of Parkinson’s. We report that nicotine reduces the abundance of SIRT6 in neuronal culture and brain tissue. We find that reduction of SIRT6 is partly responsible for neuroprotection afforded by nicotine. Additionally, SIRT6 abundance is greater in Parkinson’s patient brains, and decreased in the brains of tobacco users. We also identify SNPs that promote SIRT6 expression and simultaneously associate with an increased risk of Parkinson’s. Furthermore, brain-specific SIRT6 knockout mice are protected from MPTP-induced Parkinson’s, while SIRT6 overexpressing mice develop more severe pathology. Our data suggest that SIRT6 plays a pathogenic and pro-inflammatory role in Parkinson’s and that nicotine can provide neuroprotection by accelerating its degradation. Inhibition of SIRT6 may be a promising strategy to ameliorate Parkinson’s and neurodegeneration.
- 8 November 2018
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 6 (1) , 120
Open AccessNicotine promotes neuron survival and partially protects from Parkinson’s disease by suppressing SIRT6
Parkinson’s disease is characterized by progressive death of dopaminergic neurons, leading to motor and cognitive dysfunction. Epidemiological studies consistently show that the use of tobacco reduces the risk of Parkinson’s. We report that nicotine reduces the abundance of SIRT6 in neuronal culture and brain tissue. We find that reduction of SIRT6 is partly responsible for neuroprotection afforded by nicotine. Additionally, SIRT6 abundance is greater in Parkinson’s patient brains, and decreased in the brains of tobacco users. We also identify SNPs that promote SIRT6 expression and simultaneously associate with an increased risk of Parkinson’s. Furthermore, brain-specific SIRT6 knockout mice are protected from MPTP-induced Parkinson’s, while SIRT6 overexpressing mice develop more severe pathology. Our data suggest that SIRT6 plays a pathogenic and pro-inflammatory role in Parkinson’s and that nicotine can provide neuroprotection by accelerating its degradation. Inhibition of SIRT6 may be a promising strategy to ameliorate Parkinson’s and neurodegeneration.
- 30 August 2017
- Published by Springer Nature in Apoptosis
- Vol. 22 (11) , 1336-1343
SIRT6 knockout cells resist apoptosis initiation but not progression: a computational method to evaluate the progression of apoptosis
Apoptosis is essential for numerous processes, such as development, resistance to infections, and suppression of tumorigenesis. Here, we investigate the influence of the nutrient sensing and longevity-assuring enzyme SIRT6 on the dynamics of apoptosis triggered by serum starvation. Specifically, we characterize the progression of apoptosis in wild type and SIRT6 deficient mouse embryonic fibroblasts using time-lapse flow cytometry and computational modelling based on rate-equations and cell distribution analysis. We find that SIRT6 deficient cells resist apoptosis by delaying its initiation. Interestingly, once apoptosis is initiated, the rate of its progression is higher in SIRT6 null cells compared to identically cultured wild type cells. However, SIRT6 null cells succumb to apoptosis more slowly, not only in response to nutrient deprivation but also in response to other stresses. Our data suggest that SIRT6 plays a role in several distinct steps of apoptosis. Overall, we demonstrate the utility of our computational model to describe stages of apoptosis progression and the integrity of the cellular membrane. Such measurements will be useful in a broad range of biological applications.
- 30 August 2017
- Published by Springer Nature in Apoptosis
- Vol. 22 (11) , 1336-1343
SIRT6 knockout cells resist apoptosis initiation but not progression: a computational method to evaluate the progression of apoptosis
Apoptosis is essential for numerous processes, such as development, resistance to infections, and suppression of tumorigenesis. Here, we investigate the influence of the nutrient sensing and longevity-assuring enzyme SIRT6 on the dynamics of apoptosis triggered by serum starvation. Specifically, we characterize the progression of apoptosis in wild type and SIRT6 deficient mouse embryonic fibroblasts using time-lapse flow cytometry and computational modelling based on rate-equations and cell distribution analysis. We find that SIRT6 deficient cells resist apoptosis by delaying its initiation. Interestingly, once apoptosis is initiated, the rate of its progression is higher in SIRT6 null cells compared to identically cultured wild type cells. However, SIRT6 null cells succumb to apoptosis more slowly, not only in response to nutrient deprivation but also in response to other stresses. Our data suggest that SIRT6 plays a role in several distinct steps of apoptosis. Overall, we demonstrate the utility of our computational model to describe stages of apoptosis progression and the integrity of the cellular membrane. Such measurements will be useful in a broad range of biological applications.
MTCH2 is a conserved regulator of lipid homeostasis
Objective: More than one‐third of U.S. adults have obesity, causing an alarming increase in obesity‐related comorbidities such as type 2 diabetes. The functional role of mitochondrial carrier homolog 2 (MTCH2), a human obesity‐associated gene, in lipid homeostasis was investigated in Caenorhabditis elegans, cell culture, and mice.Methods: In C. elegans, MTCH2/MTCH‐1 was depleted, using RNAi and a genetic mutant, and overexpressed to assess its effect on lipid accumulation. In cells and mice, shRNAs against MTCH2 were used for knockdown and MTCH2 overexpression vectors were used for overexpression to study the role of this gene in fat accumulation.Results: MTCH2 knockdown reduced lipid accumulation in adipocyte‐like cells in vitro and in C. elegans and mice in vivo. MTCH2 overexpression increased fat accumulation in cell culture, C. elegans, and mice. Acute MTCH2 inhibition reduced fat accumulation in animals subjected to a high‐fat diet. Finally, MTCH2 influenced estrogen receptor 1 (ESR1) activity.Conclusions: MTCH2 is a conserved regulator of lipid homeostasis. MTCH2 was found to be both required and sufficient for lipid homeostasis shifts, suggesting that pharmacological inhibition of MTCH2 could be therapeutic for treatment of obesity and related disorders. MTCH2 could influence lipid homeostasis through inhibition of ESR1 activity.
MTCH2 is a conserved regulator of lipid homeostasis
Objective: More than one‐third of U.S. adults have obesity, causing an alarming increase in obesity‐related comorbidities such as type 2 diabetes. The functional role of mitochondrial carrier homolog 2 (MTCH2), a human obesity‐associated gene, in lipid homeostasis was investigated in Caenorhabditis elegans, cell culture, and mice.Methods: In C. elegans, MTCH2/MTCH‐1 was depleted, using RNAi and a genetic mutant, and overexpressed to assess its effect on lipid accumulation. In cells and mice, shRNAs against MTCH2 were used for knockdown and MTCH2 overexpression vectors were used for overexpression to study the role of this gene in fat accumulation.Results: MTCH2 knockdown reduced lipid accumulation in adipocyte‐like cells in vitro and in C. elegans and mice in vivo. MTCH2 overexpression increased fat accumulation in cell culture, C. elegans, and mice. Acute MTCH2 inhibition reduced fat accumulation in animals subjected to a high‐fat diet. Finally, MTCH2 influenced estrogen receptor 1 (ESR1) activity.Conclusions: MTCH2 is a conserved regulator of lipid homeostasis. MTCH2 was found to be both required and sufficient for lipid homeostasis shifts, suggesting that pharmacological inhibition of MTCH2 could be therapeutic for treatment of obesity and related disorders. MTCH2 could influence lipid homeostasis through inhibition of ESR1 activity.